fusarium has been researched along with Candidiasis, Invasive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, TS; Chim, CS; Gill, H; Hwang, YY; Khong, PL; Kwong, YL; Leung, AY; Lie, AK; Loong, F; Sim, J; Tse, AC; Tse, E | 1 |
| Pemán, J; Salavert, M | 1 |
1 review(s) available for fusarium and Candidiasis, Invasive
| Article | Year |
|---|---|
[General epidemiology of invasive fungal disease].
Topics: Antifungal Agents; Aspergillus; Candida; Candidiasis, Invasive; Comorbidity; Cross Infection; Europe; Fungemia; Fusarium; HIV Infections; Host-Pathogen Interactions; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Neoplasms; Neutropenia; Postoperative Complications; Risk Factors; Scedosporium; Spain; Species Specificity | 2012 |
1 other study(ies) available for fusarium and Candidiasis, Invasive
| Article | Year |
|---|---|
Breakthrough invasive fungal diseases during echinocandin treatment in high-risk hospitalized hematologic patients.
Topics: Adenine Nucleotides; Adult; Anidulafungin; Antibiotic Prophylaxis; Antifungal Agents; Antimetabolites, Antineoplastic; Arabinonucleosides; Candida; Candidiasis, Invasive; Caspofungin; China; Clofarabine; Cohort Studies; Cross Infection; Echinocandins; Fusariosis; Fusarium; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Lipopeptides; Lung Diseases, Fungal; Micafungin; Retrospective Studies; Risk Factors | 2014 |